TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
Thg 02 06, 2026
2 min read
9

BMO Capital has reiterated its Outperform rating for Amazon, raising the price target to $310 per share. The firm argues that investors are misinterpreting the company's heavy capital expenditure as a negative, when it should be viewed as a significant long-term growth catalyst, particularly in AI and cloud services.
The positive outlook follows a standout fourth quarter for Amazon, which featured a 400bps sequential acceleration in AWS growth to 24%, its fastest rate since the third quarter of 2022. The advertising segment also demonstrated robust health, growing 22% year over year, supported by new strategic partnerships with major streaming platforms.
BMO's analysis suggests the market is overlooking the benefits of Amazon's plan to spend $200 billion in CapEx. This investment supports rapid infrastructure expansion, including a goal to double capacity by 2027. Furthermore, Amazon's proprietary chip businesses, Graviton and Trainium, now exceed a $10 billion annual revenue run rate, validating the company's strategic investments.
While substantial CapEx can raise short-term concerns, BMO Capital views Amazon's aggressive spending as a decisive move to solidify its leadership in AI and cloud computing. The firm applauds the strategy, suggesting that the market is undervaluing the long-term returns from these critical infrastructure investments.
Q: Why does BMO believe Amazon's CapEx is a positive?
A: BMO sees the spending as a crucial investment to expand AI and cloud infrastructure, which is expected to drive significant long-term growth and solidify market leadership.
Q: What is BMO's new price target for Amazon?
A: BMO Capital raised its price target for Amazon stock to $310 per share.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles

06 Thg 02 2026
Roivant Stock Soars 15% on Positive Drug Trial Data

06 Thg 02 2026
SmartKem Stock (SMTK) Jumps on Debt Conversion Deal

06 Thg 02 2026
Galaxy Digital Stock Jumps 14% on $200M Buyback Plan

06 Thg 02 2026
Maxeon Solar Stock Soars on Aiko Patent Deal

06 Thg 02 2026
uniQure Rises on Positive Fabry Gene Therapy Trial Data

06 Thg 02 2026
Renault Faces Sales Ban in Germany Over Broadcom Patent